Your browser doesn't support javascript.
loading
App-based COVID-19 surveillance and prediction: The COVID Symptom Study Sweden
Beatrice Kennedy; Hugo Fitipaldi; Ulf Hammar; Marlena Maziarz; Neli Tsereteli; Nikolay Oskolkov; Georgios Varotsis; Camilla A Franks; Diem T Nguyen; Lampros Spiliopoulos; Hans-Olov Adami; Jonas Björk; Stefan Engblom; Katja Fall; Anna Grimby-Ekman; Jan-Eric Litton; Mats Martinell; Anna Oudin; Torbjörn Sjöström; Toomas Timpka; Carole H Sudre; Mark S Graham; Julien Lavigne du Cadet; Andrew T. Chan; Richard Davies; Sajaysurya Ganesh; Anna May; Sébastien Ourselin; Joan Capdevila Pujol; Somesh Selvachandran; Jonathan Wolf; Tim D Spector; Claire J Steves; Maria F Gomez; Paul W Franks; Tove Fall.
Afiliação
  • Beatrice Kennedy; Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Sweden
  • Hugo Fitipaldi; Genetic and Molecular Epidemiology Unit, Department of Clinical Sciences, Lund University Diabetes Centre, Lund University, Sweden
  • Ulf Hammar; Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Sweden
  • Marlena Maziarz; Diabetic Complications Unit, Department of Clinical Sciences in Malmö, Lund University Diabetes Centre, Sweden
  • Neli Tsereteli; Genetic and Molecular Epidemiology Unit, Department of Clinical Sciences, Lund University Diabetes Centre, Lund University, Sweden
  • Nikolay Oskolkov; Department of Biology, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Lund University, Sweden
  • Georgios Varotsis; Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Sweden
  • Camilla A Franks; Diabetic Complications Unit, Department of Clinical Sciences in Malmö, Lund University Diabetes Centre, Sweden
  • Diem T Nguyen; Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Sweden
  • Lampros Spiliopoulos; Diabetic Complications Unit, Department of Clinical Sciences in Malmö, Lund University Diabetes Centre, Sweden; Skåne University Hospital, Malmö, Sweden
  • Hans-Olov Adami; Clinical Effectiveness Group, Institute of Health and Society, University of Oslo, Oslo, Norway; Dept of Medical Epidemiology and Biostatistics, Karolinska Inst
  • Jonas Björk; Division of Occupational and Environmental Medicine, Lund University, Sweden; Clinical Studies Sweden, Forum South, Skåne University Hospital, Lund, Sweden
  • Stefan Engblom; Division of Scientific Computing, Department of Information Technology, Uppsala University, Sweden
  • Katja Fall; Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden; Integrative Epidemiology, Institute of Environmental Med
  • Anna Grimby-Ekman; Biostatistics, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
  • Jan-Eric Litton; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Sweden
  • Mats Martinell; Department of Public Health and Caring Sciences, Uppsala University, Sweden; Primary Care and Health, Region Uppsala, Sweden
  • Anna Oudin; Division for Occupational and environmental medicine, Lund University, Sweden; Department of Public Health and Clinical Medicine, Section of Sustainable Health,
  • Torbjörn Sjöström; Novus International Group AB, Sweden
  • Toomas Timpka; Department of Medical and Health Sciences, Linkoping University, Sweden
  • Carole H Sudre; MRC Unit for Lifelong Health and Ageing at UCL, University College London, London, UK; Centre for Medical Image Computing, University College London, London, UK
  • Mark S Graham; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK
  • Julien Lavigne du Cadet; ZOE Limited
  • Andrew T. Chan; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • Richard Davies; ZOE Limited
  • Sajaysurya Ganesh; ZOE Limited
  • Anna May; ZOE Limited
  • Sébastien Ourselin; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK
  • Joan Capdevila Pujol; ZOE Limited
  • Somesh Selvachandran; ZOE Limited
  • Jonathan Wolf; ZOE Limited
  • Tim D Spector; Department of Twin Research and Genetic Epidemiology, King's College London, London, UK
  • Claire J Steves; Department of Twin Research and Genetic Epidemiology, King's College London, London, UK
  • Maria F Gomez; Diabetic Complications Unit, Department of Clinical Sciences in Malmö, Lund University Diabetes Centre, Sweden
  • Paul W Franks; Genetic and Molecular Epidemiology Unit, Department of Clinical Sciences, Lund University Diabetes Centre, Lund University, Sweden
  • Tove Fall; Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Sweden
Preprint em Inglês | medRxiv | ID: ppmedrxiv-21258691
ABSTRACT
The app-based COVID Symptom Study was launched in Sweden in April 2020 to contribute to real-time COVID-19 surveillance. We enrolled 143,531 study participants ([≥]18 years) who contributed 10.6 million daily symptom reports between April 29, 2020 and February 10, 2021. Data from 19,161 self-reported PCR tests were used to create a symptom-based model to estimate the individual probability of symptomatic COVID-19, with an AUC of 0.78 (95% CI 0.74-0.83) in an external dataset. These individual probabilities were used to estimate daily regional COVID-19 prevalence, which were in turn used together with current hospital data to predict next week COVID-19 hospital admissions. We found that this hospital prediction model demonstrated a lower median absolute percentage error (MdAPE 25.9%) across the five most populated regions in Sweden during the first pandemic wave than a model based on case notifications (MdAPE 30.3%). During the second wave, the error rates were similar. When applying the same model to an English dataset, not including local COVID-19 test data, we observed MdAPEs of 22.3% and 19.0%, respectively, highlighting the transferability of the prediction model.
Licença
cc_by
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Estudo observacional / Estudo prognóstico Idioma: Inglês Ano de publicação: 2021 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Estudo observacional / Estudo prognóstico Idioma: Inglês Ano de publicação: 2021 Tipo de documento: Preprint
...